STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 63 filers reported holding STEMLINE THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $310,000 | -15.1% | 36,208 | +6.0% | 0.01% | -16.7% |
| Q4 2016 | $365,000 | +162.6% | 34,153 | +166.9% | 0.01% | +200.0% |
| Q3 2016 | $139,000 | +101.4% | 12,796 | +26.3% | 0.00% | +100.0% |
| Q2 2016 | $69,000 | -26.6% | 10,133 | -50.0% | 0.00% | +100.0% |
| Q1 2016 | $94,000 | +44.6% | 20,266 | +97.2% | 0.00% | -50.0% |
| Q4 2015 | $65,000 | -45.8% | 10,275 | -24.7% | 0.00% | -33.3% |
| Q3 2015 | $120,000 | -25.5% | 13,641 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $161,000 | -18.3% | 13,641 | 0.0% | 0.00% | -25.0% |
| Q1 2015 | $197,000 | -9.6% | 13,641 | +6.8% | 0.00% | -20.0% |
| Q4 2014 | $218,000 | +24.6% | 12,771 | -9.0% | 0.01% | 0.0% |
| Q3 2014 | $175,000 | – | 14,028 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 1,471,518 | $23,618,000 | 8.40% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 492,930 | $7,862,000 | 3.02% |
| Consonance Capital Management LP | 2,747,198 | $44,093,000 | 2.84% |
| NEXTHERA CAPITAL LP | 559,517 | $8,980,000 | 1.39% |
| Eventide Asset Management | 1,086,400 | $17,437,000 | 0.72% |
| Virtus ETF Advisers LLC | 45,850 | $736,000 | 0.65% |
| KNOTT DAVID M | 90,000 | $1,445,000 | 0.54% |
| Polar Capital LLP | 1,912,605 | $30,697,000 | 0.18% |
| Artal Group S.A. | 400,000 | $6,420,000 | 0.14% |
| J. Goldman & Co LP | 100,000 | $1,605,000 | 0.08% |